Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation. - Wikidata - wikimedia - TriplyDB

Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.

Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.

http://www.wikidata.org/entity/Q37662291

about

Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis.Association between reversal in the expression of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel and age-related atrial fibrillation Role of inflammation in atrial fibrillation pathophysiology and management.The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.Platelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review.Association of β1-Adrenergic, M2-Muscarinic Receptor Autoantibody with Occurrence and Development of Nonvalvular Atrial Fibrillation.Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic Stroke Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation.Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction.

P2860

Q33712583-5C89ECE9-EF74-4B9C-B2CF-3385D4FC538A Q34567021-CB069024-7119-42EA-AA8F-6028F7E87090 Q35688023-4D480543-72D9-42F9-A9D4-B265839AC376 Q36920563-AB17538B-36BC-460B-9571-783F8DF92530 Q38677229-8E8D0FB2-DFDD-4EE4-A6E7-79638AF5EE18 Q39182923-BABF26E4-E1EA-4636-95D3-D4A2AF3819DA Q40468778-528B6B7D-EB71-446F-B917-C060A2561382 Q41146607-0CFC65D9-FFE4-434D-B66C-5F91787395A6 Q42265982-50E712C0-CC0C-4E7E-8EA2-1877759A44B6 Q47423482-EDB85CC5-24E0-4739-AAC1-489704DC9CB8 Q47759940-7716AE54-0E64-4396-B605-87F8C0DE357B Q49850138-12C4216D-27C4-4B7B-AA24-5213410078E5

P2860

Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.

http://www.wikidata.org/entity/Q37662291

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel fibro-inflammation marke ...... -valvular atrial fibrillation.

@en

Novel fibro-inflammation marke ...... -valvular atrial fibrillation.

@nl

type

label

Novel fibro-inflammation marke ...... -valvular atrial fibrillation.

@en

Novel fibro-inflammation marke ...... -valvular atrial fibrillation.

@nl

prefLabel

Novel fibro-inflammation marke ...... -valvular atrial fibrillation.

@en

Novel fibro-inflammation marke ...... -valvular atrial fibrillation.

@nl

P1433

Q37662291-09A0FE82-F4D4-4718-A4CF-A20A400567EB

P1476

Q37662291-2266AC1A-A7E6-477A-969D-47EB22FB0309

P2093

Q37662291-0F03DC87-93BE-4A29-821B-23F5B50BF984

Q37662291-10F905ED-7B24-48E4-AF47-F71DA766913A

Q37662291-1A407447-71CE-4DEF-9DBE-36D098F4A818

Q37662291-4A2C163F-32A2-4D82-9075-F69544C017FF

Q37662291-55600996-C43E-44EF-AFB9-AB30D36A6B56

Q37662291-8487C1B2-7FF6-448C-AADA-1393CF646A61

P2860

Q37662291-1AB88222-836D-49D9-BC9A-473897334D9D

Q37662291-220CE041-E56E-4D7C-B518-F1F7EBD1903B

Q37662291-2681014D-3C37-4B30-8DFD-6A1D08958CB5

Q37662291-2A2FDD49-BA38-4A41-B558-92DC81243EC8

Q37662291-2D5CD610-0015-4FFB-8BE4-02456A993B22

Q37662291-332C78CE-7FC3-4953-9D6F-FC327DFEBD3A

Q37662291-35977BAB-29FA-4732-9D3F-4AAA9E3D03CA

Q37662291-36D54248-047C-4F8F-8F03-9138A8B2FBE6

Q37662291-3D6418B4-F11B-4A16-963A-BD75B81C8B05

Q37662291-3DD706E4-8E5D-41B2-9C96-B56CA6EEFDA9

P304

Q37662291-373268CC-8941-46CA-AD3C-5BAD4ECA77ED

P31

Q37662291-B3D7BC1E-77A0-410F-810C-07DD2B8484F3

P356

Q37662291-85562FC3-F2D8-4CF2-A83D-8C3D4307D867

P478

Q37662291-67894E3E-9671-4207-A924-073E2FF37EA1

P50

Q37662291-8795721C-FC18-411C-90AC-9712415D6D6B

P577

Q37662291-5730385B-236F-4C48-9B9D-F25BFED07898

P698

Q37662291-7EA7CB92-FD79-46F3-B022-BBFB47D2E300

P921

Q37662291-CCAA2C98-0DFA-47DB-BA6C-0C7EB9311DF5

Q37662291-F928AF60-D70C-4A41-8271-3D339BBE8B72

P932

Q37662291-25235378-79DD-4899-ACD2-AF9CD9F13F28

P356

P1433

Medical Science Monitor

P1476

Novel fibro-inflammation marke ...... n-valvular atrial fibrillation

@en

P2093

Abdurrahman Tasal

http://www.w3.org/2001/XMLSchema#string

Ercan Erdogan

http://www.w3.org/2001/XMLSchema#string

Furkan U Ertem

http://www.w3.org/2001/XMLSchema#string

Mehmet Akif Vatankulu

http://www.w3.org/2001/XMLSchema#string

Omer Goktekin

http://www.w3.org/2001/XMLSchema#string

Sıtkı Kucukbuzcu

http://www.w3.org/2001/XMLSchema#string

P2860

High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis

Lipocalin-2/neutrophil gelatinase-B associated lipocalin is strongly induced in hearts of rats with autoimmune myocarditis and in human myocarditis

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.

Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation.

The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.

High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.

Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation

Relation of hs-CRP and BNP levels with the atrial spontaneous echo contrast and thrombi in permanent atrial fibrillation patients with different etiologies.

Beneficial effects of an angiotensin-II receptor blocker on structural atrial reverse-remodeling in a rat model of ischemic heart failure.

P304

463-470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.890635

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24651058

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

3965288

http://www.w3.org/2001/XMLSchema#string